miRNA Signatures as Predictors of Therapy Response in Castration-Resistant Prostate Cancer: Insights from Clinical Liquid Biopsies and 3D Culture Models
These results indicate that miRNAs could serve as non-invasive biomarkers for predicting therapeutic outcomes, facilitating a more personalized approach to CRPC treatment. This study provides a novel perspective on treatment strategies for CRPC, emphasizing the role of miRNAs in improving therapeutic precision and efficacy in this complex disease.
Authors
- Mónica Alethia Cureño-Díaz (ORCID: https://orcid.org/0000-0002-4556-637X)
- María Elizbeth Álvarez-Sánchez (ORCID: https://orcid.org/0000-0002-9212-4451)
- Jonathan Puente-Rivera (ORCID: https://orcid.org/0000-0001-6941-6248)
- Stephanie I. Núñez-Olvera
- Erika Gómez-Zamora (ORCID: https://orcid.org/0000-0002-0488-7900)
- Elisa Elvira Figueroa-Angulo (ORCID: https://orcid.org/0000-0002-5615-7854)
- Verónica Fernández-Sánchez (ORCID: https://orcid.org/0000-0001-9732-2265)
- Estibeyesbo Said Plascencia-Nieto (ORCID: https://orcid.org/0009-0002-2949-4924)
Institutions
- Universidad Autónoma de Tlaxcala (MX)
- Universidad Autónoma de la Ciudad de México (MX)
- Hospital Juárez de México (MX)
- Instituto Politécnico Nacional (MX)
- Universidad Nacional Autónoma de México (MX)
Publication Details
- Journal
- Genes
- Published
- 2025-02-01
- DOI
- https://doi.org/10.3390/genes16020180
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Universidad Autónoma de la Ciudad de México